Key Predictors of IgG Seropositivity in Individuals Exposed to SARS-CoV-2 Prior to Vaccine Rollout
Archives of Advances in Biosciences,
Vol. 16 No. 1 (2025),
2 March 2025
,
Page 1-9
https://doi.org/10.22037/aab.v15i1.46911
Abstract
Introduction: The COVID-19 pandemic has highlighted the need to understand factors influencing the immune response to SARS-CoV-2. Immunoglobulin G (IgG) antibodies serve as indicators of prior exposure and potential immunity. This study aims to identify demographic, clinical, and exposure-related predictors of IgG positivity in individuals exposed to SARS-CoV-2 before the initiation of vaccination programs.
Materials and Methods: A cross-sectional study was conducted among 944 participants recruited from healthcare facilities. Eligible participants were aged 18 years or older, presented with COVID-19 symptoms or known exposure to confirmed SARS-CoV-2 cases, and had not received a COVID-19 vaccine. Data were collected via structured questionnaires, including demographics, clinical symptoms, and exposure history, and analyzed using logistic regression. IgG antibodies were detected using the SARS-CoV-2 IgG ELISA method.
Results: IgG antibodies were detected in 75.0% of participants. Younger age (B = -0.026, p < 0.001), divorced marital status (B = 0.973, p = 0.021, Exp(B) = 2.65), recent international travel (B = 0.953, p = 0.047, Exp(B) = 2.594), and symptoms such as runny nose (B = 2.561, p = 0.012, Exp(B) = 12.96), nausea (B = 1.614, p = 0.048, Exp(B) = 5.025), and lack of appetite (B = 1.366, p = 0.049, Exp(B) = 3.918) were significant predictors of IgG positivity. Each additional year of age was associated with a 2.6% reduction in the likelihood of IgG positivity. The model achieved 75.4% classification accuracy with an AUC of 0.640, indicating moderate predictive performance.
Conclusion: This study demonstrates the importance of demographic, clinical, and exposure-related factors in predicting IgG positivity. The findings enhance understanding of immune responses to SARS-CoV-2 and provide insights that can guide public health strategies in mitigating the pandemic's impact.
- COVID 19
- SARS CoV 2
- IgG antibodies
- Immune response
- Logistic regression
How to Cite
References
Wu, J., Liang, B., Chen, C., Wang, H., Fang, Y., Shěn, S., … & Zheng, X. (2020). Sars-cov-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic covid-19.
[DOI:10.1038/s41467-021-22034-1]
Lytton, S. D., Yeasmin, M., Ghosh, A. K., Bulbul, M. R. H., Molla, M. M. A., Herr, M., … & Shamsuzzaman, A. K. M. (2021). Detection of anti-nucleocapsid antibody in covid-19 patients in bangladesh is not correlated with previous dengue infection. Pathogens, 10(6), 637.
[DOI:10.3390/pathogens10060637] [PMID] [PMCID]
Sze, S., Pan, D., Nevill, C., Gray, L., Martin, C., Nazareth, J., … & Pareek, M. (2020). Ethnicity and clinical outcomes in covid-19: a systematic review and meta-analysis. Eclinicalmedicine, 29-30, 100630. [DOI:10.1016/j.eclinm.2020.100630] [PMID] [PMCID]
Holmes, L., Enwere, M., Williams, J., Ogundele, B., Chavan, P., Piccoli, T., … & Dabney, K. (2020). Black–white risk differentials in covid-19 (sars-cov2) transmission, mortality and case fatality in the united states: translational epidemiologic perspective and challenges. International Journal of Environmental Research and Public Health, 17(12), 4322. [DOI:10.3390/ijerph17124322] [PMID]
Sun, B., Feng, Y., Mo, X., Zheng, P., Wang, Q., Li, P., … & Chen, L. (2020). Kinetics of sars-cov-2 specific igm and igg responses in covid-19 patients. Emerging Microbes & Infections, 9(1), 940-948. [DOI:10.1080/22221751.2020.1762515]
[PMID]
To, K., Tsang, O., Leung, W., Tam, A., Wu, T., Lung, D., … & Yuen, K. (2020). Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by sars-cov-2: an observational cohort study. The Lancet Infectious Diseases, 20(5), 565-574.[DOI:10.1016/S1473-3099(20)30196-1]
Galanis, P., Vraka, I., Fragkou, D., Bilali, A., & Kaitelidou, D. (2021). Seroprevalence of sars-cov-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. Journal of Hospital Infection, 108, 120-134. [DOI:10.1016/j.jhin.2020.11.008]
Lumley, S., Wei, J., O’Donnell, D., Stoesser, N., Matthews, P., Howarth, A., … & Eyre, D. (2020). The duration, dynamics and determinants of sars-cov-2 antibody responses in individual healthcare workers.
[DOI:10.1093/cid/ciab004]
Córdova, E., Bacelar, B., Nieto, F., Garibaldi, F., Machuca, M., Badia, M., … & Rodríguez, C. (2021). Sars-cov-2 igg response in symptomatic and asymptomatic covid-19-infected healthcare workers. Occupational Medicine, 71(4-5), 215-218. [DOI:10.1093/occmed/kqab061] [PMID]
Cervia, C., Nilsson, J., Zurbuchen, Y., Valaperti, A., Schreiner, J., Wolfensberger, A., … & Boyman, O. (2021). Systemic and mucosal antibody responses specific to sars-cov-2 during mild versus severe covid-19. Journal of Allergy and Clinical Immunology, 147(2), 545-557.e9.
[DOI: 10.1016/j.jaci.2020.10.040] [PMID] [PMCID]
Butterfield, T., Bruce-Mowatt, A., Phillips, Y., Brown, N., Francis, K., Brown, J., … & Anzinger, J. (2020). Assessment of commercial sars-cov-2 antibody assays, jamaica.
[DOI:10.1016/j.ijid.2021.02.059] [PMID]
Kaku, N., Nishimura, F., Y, S., Tachiki, R., Sakai, H., Sasaki, D., … & Yanagihara, K. (2021). Evaluation of anti-sars-cov-2 antibody testing in asymptomatic or mild covid-19 patients in outbreak on a cruise ship.
[DOI:10.1101/2021.03.10.21253064]
Martínez, P., García, P., Salas, M., Sánchez, R., Avendaño-Ortíz, J., Guerrero-Monjo, S., … & Fresno, C. (2021). Sars-cov-2 igg seropositivity in a cohort of 449 non-hospitalized individuals during spanish covid-19 lockdown. Scientific Reports, 11(1).
[DOI:10.1038/s41598-021-00990-4][PMID] [PMCID]
Hu, F., Shang, X., Chen, M., & Zhang, C. (2020). Joint detection of serum igm/igg antibody is an important key to clinical diagnosis of sars-cov-2 infection. [PMID]
Mahallawi, W. and Al‐Zalabani, A. (2021). The seroprevalence of sars-cov-2 igg antibodies among asymptomatic blood donors in saudi arabia. Saudi Journal of Biological Sciences, 28(3), 1697-1701.
[DOI:10.1016/j.sjbs.2020.12.009] [PMID] [PMCID]
Coşgun, Y., Altaş, A., Kuzucu, E., Güner, R., Erdinç, Ş., Eser, F., … & Korukluoğlu, G. (2021). Role of rapid antibody and elisa tests in the evaluation of serological response in patients with sars-cov-2 pcr positivity. Folia Microbiologica. [DOI:10.1007/s12223-021-00861-5] [PMID]
Yalçınsoy, K. (2024). Tubulointerstitial nephritis and uveitis syndrome during the covid-19 pandemic: a case series. Turkish Journal of Ophthalmology, 54(1), 5-10.
[DOI: 10.4274/tjo.galenos.2023.24280][PMID]
- Abstract Viewed: 326 times
- pdf Downloaded: 179 times